Results demonstrated statistically significant effects on biomarkers that predict ALS disease progression and severity Evidence of brain penetration, target engagement, and potential anti-seizure effects demonstrated through biomarkers for TMS-EMG and EEG Safety and tolerability profile...
Read More Details
Finally We wish PressBee provided you with enough information of ( QurAlis Announces Topline Data From its Phase 1 Clinical Trial of QRL-101 Evaluating Biomarkers of ALS and Epilepsy in Healthy Volunteers )
Also on site :
- Vacaville carjacking suspects arrested in Fairfield; suspect shot by police
- Oil has jumped on the CNN report Israel is planning to attack Iran nuclear facilities
- Duff Goldman Reveals His 'Curvy Path' to Getting Healthy After Losing 42 Lbs (Exclusive)